## **Core Concept**
The question tests knowledge on the treatment of Methicillin-resistant Staphylococcus aureus (MRSA) infections. MRSA is a type of bacteria that is resistant to many antibiotics, including methicillin and other penicillins and penicillin-like medications. The management of MRSA infections requires specific antibiotics that can effectively target and eliminate the bacteria.

## **Why the Correct Answer is Right**
The correct answer, , is a glycopeptide antibiotic that is effective against MRSA. It works by inhibiting cell wall synthesis in bacteria, which ultimately leads to bacterial cell death. Vancomycin is considered a drug of choice for treating serious MRSA infections, including skin and soft tissue infections, bloodstream infections, and endocarditis. Its effectiveness against MRSA has made it a critical component in the management of these infections.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because, although it might have some activity against certain Gram-positive bacteria, it is not the first-line treatment for MRSA infections.
- **Option B:** is incorrect because it is not typically used as a primary treatment for MRSA infections. It may have some efficacy but is not considered a first-line agent.
- **Option D:** is incorrect because, while it can be used in certain cases of MRSA infection, it is not considered the drug of choice for MRSA infections.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that vancomycin is a drug of choice for MRSA infections, but its use must be monitored closely due to potential nephrotoxicity and ototoxicity. Additionally, the emergence of vancomycin-resistant Enterococci (VRE) has made it essential to use vancomycin judiciously.

## **Correct Answer:** . Vancomycin